Bibliography
- Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26(2):225-39
- Mees G, Dierckx R, Vangestel C, et al. Molecular imaging of hypoxia with radiolabelled agents. Eur J Nucl Med Mol Imaging 2009;36(10):1674-86
- Albiach CF, Moreno AC, Cordon MR, et al. Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment. Clin Transl Oncol 2010;12(1):22-6
- Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004;9(Suppl 5):4-9
- Wang W, Lee NY, Georgi J, et al. Pharmacokinetic analysis of hypoxia 18F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med 2010;51(1):37-45
- Price JM, Robinson SP, Koh DM. Imaging hypoxia in tumours with advanced MRI. Q J Nucl Med Mol Imaging 2013;57(3):257-70
- Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumors with potential clinical applicability. Br J Cancer 1981;43(4):546-50
- Dierckx RA, Van de Wiele C. FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging 2008;35(8):1544-9
- Van Baardwijk A, Dooms C, van Suylen RJ, et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlated with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007;43(9):1392-8
- Perche F, Biswas S, Wang T, et al. Hypoxia-targeted siRNA delivery. Angew Chem Int Ed Engl 2014;53(13):3362-6
- Peitzsch C, Perrin R, Hill RP, et al. Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol 2014;90(8):636-52
- Hsiao HT, Xing L, Deng X, et al. Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cells. Oncol Rep 2014;32(2):723-9
- Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med 1995;22(3):265-80
- Takasawa M, Moustafa RR, Baron JC. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke 2008;39(5):1629-37
- Maeda K, Osato T, Umezawa H. A new antibiotic, azomycin. J Antibiot (Tokyo) 1953;6(4):182
- Edwards DI. Nitroimidazole drugs – action and resistance mechanisms. II. Mechanisms of resistance. J Antimicrob Chemother 1993;31(2):201-10
- Nagasawa H, Uto Y, Kirk KL, et al. Design of hypoxia-targeting drugs as new cancer chemotherapeutics. Biol Pharm Bull 2006;29(12):2335-42
- Anees P, Sreejith S, Ajayaghosh A. Self-assembled near-infrared dye nanoparticles as a selective protein sensor by activation of a dormant fluorophore. J Am Chem Soc 2014;136(38):13233-9
- Karagoz B, Yeow J, Esser L, et al. An efficient and highly versatile synthetic route to prepare iron oxide nanoparticles/nanocomposites with tunable morphologies. Langmuir 2014;30(34):10493-502
- Jae Hyung Park. Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases. US 20140141084 A1 (2006)